Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study

Go back to Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study
(NASDAQ: KRYS) Delayed: 346.39 -1.7 (0.49%)
Previous Close $348.09    52 Week High
Open $347.56    52 Week Low
Day High $349.66    P/E N/A 
Day Low $344.26    EPS
Volume 16,993